Wir sind mit live! Mehr erfahren

Electromed

ELMD

Börsenwert 227 Mio. $

27,42 USD

-0,61

2,18 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

1 Tag

-2,18 %

5 Tage

-0,94 %

1 Monat

4,86 %

3 Monate

-35,93 %

6 Monate

8 %

Seit Jahresbeginn

0,11 %

1 Jahr

12,79 %

5 Jahre

154,12 %

10 Jahre

523,18 %

Profil: Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

Mitarbeiter: 197

Gesundheitswesen Medizintechnik

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 28,6 %

Neutral 71,4 %

Negativ 0 %

Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event.

Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event

Electromed: Contrarian 'Buy' With SmartVest

Electromed's direct-to-patient model, broad payer coverage, and disciplined sales execution support durable SmartVest growth. The bronchiectasis market remains substantially underpenetrated, leaving a long runway for greater HFCWO adoption. Hospital revenue is volatile, but the channel remains small and full-year hospital sales still increased.

Electromed: Contrarian 'Buy' With SmartVest

Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript

Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript

Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript

Zacks Investment Research

Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates

Electromed, Inc. (ELMD) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.25 per share a year ago.

Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates

Electromed Announces CEO's Planned Retirement

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces CEO's Planned Retirement.

Electromed Announces CEO's Planned Retirement

Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results.

Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results

Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026.

Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026

Zacks Investment Research

4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX

LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.

4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX

Zacks Investment Research

Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why

Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks Investment Research

Here's Why Momentum in Electromed (ELMD) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Here's Why Momentum in Electromed (ELMD) Should Keep going

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt